Health
Moderna COVID-19 vaccine successful against emerging variants – European Pharmaceutical Review
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Posted: 27 January 2021 | Victoria Rees (European Pharmaceutical Review) | No comments yet
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Moderna has announced results from in vitro neutralisation studies of sera from individuals vaccinated with the company’s COVID-19 vaccine showing activity against emerging strains of SARS-CoV-2.
According to the company, vaccination with the Moderna COVID-19 vaccine…
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News9 hours agoLune Has Launched a Loyalty Program to Reward Your Love of World-Famous Croissants and Other Tasty Pastries